Phytochemical-Infused Chitosan Biocomposites: Cytotoxic, Antidiabetic, and Anticoagulant Potential of Vaccinium and Zingiber Extracts
Maria Sharon Velraj1, Arvina Rajasekar1★★ Corresponding author
- 1Department of Periodontology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, INDIA.
CORRESPONDENCE
Arvina Rajasekar
Associate Professor, Department of Periodontology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai-600077, Tamil Nadu, INDIA.
Received: 17-02-2025; Revised: 22-04-2025; Accepted: 09-06-2025.
Volume 17, Issue 3 · pp. 983–988 · PUBLISHED Jul-Sep 2025 · DOI: 10.5530/pres.20252284
View on Pharmacogn. Res. original site ↗
ABSTRACT
Background The integration of plant-derived bioactives with natural polymers offers a sustainable approach to therapeutic biomaterials. Vaccinium sect. Cyanococcus (blueberry) and Zingiber officinale (ginger) are known for their antidiabetic and anticoagulant properties, while chitosan serves as a biodegradable, biocompatible carrier. Aim To develop a chitosan-based biocomposite loaded with V. cyanococcus and Z. officinale extracts and evaluate its in vitro antidiabetic, anticoagulant, and cytotoxic activities. Materials and Methods Biocomposites were prepared by incorporating aqueous extracts of V. cyanococcus and Z. officinale into a chitosan matrix. Antidiabetic activity was assessed via α-amylase and α-glucosidase inhibition assays. Anticoagulant activity was evaluated using clotting time analysis. Biocompatibility was tested via the brine shrimp lethality assay. Data were analyzed statistically, with significance set at p<0.05. Results The biocomposite showed significant, dose-dependent inhibition of α-amylase (48.03-85.09%) and α-glucosidase (47.03-84.04%) activities, comparable to the standard drug acarbose (p>0.05). Clotting time in the treated group (8.40±0.10 min) showed a mild, non-significant decrease compared to control (8.60±0.10 min). Cytotoxicity was minimal at lower concentrations, with nauplii viability remaining above 60% even at the highest dose after 48 hr. Conclusion The chitosan-based biocomposite enriched with V. cyanococcus and Z. officinale exhibits promising antidiabetic and mild anticoagulant activity with acceptable biocompatibility. These findings support its potential use in managing metabolic and thrombotic conditions.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Velraj, M. S., & Rajasekar, A. (2025). Phytochemical-Infused Chitosan Biocomposites: Cytotoxic, Antidiabetic, and Anticoagulant Potential of Vaccinium and Zingiber Extracts. Pharmacognosy Research, 17(3), 983–988. https://doi.org/10.5530/pres.20252284
